Page last updated: 2024-12-11
ibuprofen arginine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
ibuprofen arginine: trade name Spedifen [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 9864669 |
CHEMBL ID | 4594450 |
SCHEMBL ID | 43030 |
MeSH ID | M0277856 |
Synonyms (18)
Synonym |
---|
ibuprofen arginine salt |
D08058 |
zafen (tn) |
ibuprofen arginine |
AKOS016012259 |
57469-82-6 |
ibuprofen l-arginine |
SCHEMBL43030 |
(s)-2-amino-5-guanidinopentanoic acid compound with 2-(4-isobutylphenyl)propanoic acid (1:1) |
DTXSID30432072 |
mfcd23701748 |
AS-10612 |
(2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;2-[4-(2-methylpropyl)phenyl]propanoic acid |
AMY520 |
l-arginine, |a-methyl-4-(2-methylpropyl)benzeneacetate |
Q27294011 |
CHEMBL4594450 |
(s)-2-amino-5-guanidinopentanoicacidcompoundwith2-(4-isobutylphenyl)propanoicacid(1:1) |
Research Excerpts
Pharmacokinetics
Bioavailability
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
"Co-amorphous mixtures have rarely been formulated as oral dosage forms, even though they have been shown to stabilize amorphous drugs in the solid state and enhance the dissolution properties of poorly soluble drugs." | ( Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods. Korhonen, O; Laitinen, R; Ojarinta, R; Saarinen, J; Strachan, CJ, 2018) | 0.48 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (22)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 12 (54.55) | 29.6817 |
2010's | 8 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 50.27
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (50.27) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 11 (50.00%) | 5.53% |
Reviews | 1 (4.55%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (45.45%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Clinical Trials (2)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized, Open-label, Single-center, Single-dose, Two Treatment, Two-sequence, Two-period, Two-cohort, Two-way Crossover Bioequivalence Study of Two Ibuprofen Arginine Granules 400 mg Formulations Under Fasting and Fed Conditions in Chinese Healthy Ad [NCT05737069] | Phase 1 | 84 participants (Actual) | Interventional | 2023-04-19 | Completed | ||
Pain Reduction and Changes in Upper Limb Function Produced by Physiotherapy, Ibuprofen Arginine, Gabapentin and the Absence of Treatment, in Carpal Tunnel Syndrome [NCT04025203] | Phase 4 | 80 participants (Anticipated) | Interventional | 2019-08-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |